HOME >> MEDICINE >> NEWS
Lack of funds hampering important child health study

US Congress should boost funding for an important study to identify the risk factors for childhood chronic disease, states an editorial in this week's issue of THE LANCET.

Environmental factors have a crucial role in determining the health of the world's 2.3 billion children. But exactly which risk factors contribute to childhood chronic disease is often unknown. The National Children's Study aims to track the health of 100,000 children across the USA from birth to their 21st birthday. The study will look at the environmental--including physical, chemical, biological, and psycho-social--influences on children's health and development. The researchers estimate that they will need US$2.7 billion over 25 years, but they have hit problems securing the necessary funds. The study has already been delayed by a year. For the 2005 fiscal year US Congress appropriated less than half the $27 million the researchers were counting on, and for the fiscal year 2006 President Bush has requested that Congress appropriate only $12 million--far less that the study needs to stay on track.

The Lancet comments: "American children are more likely than ever to develop chronic diseases such as obesity, diabetes, asthma, and behavioural disorders. According to one estimate, the annual disease burden from the ten most common health problems that afflict children is around $400 billion a year in the USA alone. From a purely economic point of view, therefore, the National Children's Study could pay for itself many times over if it reduces this burden by as little as 1% a yearUS Congress needs to have the long-term vision to leave a legacy to help future generations of children, not just in the USA but throughout the world."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
19-May-2005


Page: 1

Related medicine news :

1. Help the Aged funds the University of Nottingham to research pain affecting older people
2. $15M Northwestern grant funds heart research
3. Rotary funds new research
4. NHGRI funds assessment of public attitudes about population-based studies on genes and environment
5. Estate of fashion designer Geoffrey Beene donates funds to Memorial Sloan-Kettering Cancer Center
6. NIH funds $2 million magnetic resonance system at Yale
7. $5.8 million funds 2 new studies on best treatments for ADHD
8. $10 million gift funds innovative predictive health study
9. Rice, M. D. Anderson win funds for bench to bed training
10. $4.5 million CDC grant funds Yale Center for Public Health Preparedness
11. GlaxoSmithKline funds $1.65 million effort for UNC-Duke public health care partnership

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... New SUPRO® ... ready-to-drink, high-protein beverages by helping beverage manufacturers more effectively manage protein costs. “Soy ... cost savings as well as more stable pricing over time. Now it’s even ...
(Date:4/25/2017)... ... 2017 , ... Bellus Medical, a leader in medical aesthetics, ... class of photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically ... aging, and minimize the appearance of pores – all with minimal downtime and ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and funding ... randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced ...
(Date:4/25/2017)... Boulder, CO (PRWEB) , ... April 25, 2017 ... ... Law and Liberty attempts to compare student test score performance for the 2015-16 ... one of the state’s voucher programs. Though it highlights important patterns in student ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... a modern procedure that achieves results in a fraction of the time as ... Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment with or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology:
Cached News: